Loading quotes...

Forecast

There is no analyst data available for this company.

News Go to news feed

MPH Health Care approves 2025 financial statements and proposes dividend of €5.00

The supervisory board of MPH Health Care has approved the annual and consolidated financial statements for 2025 presented by the management board and has adopted the annual financial statements. The management board and supervisory board will propose a dividend of €5.00 per dividend-entitled share to the annual general meeting. The 2025 annual report is expected to be published on 27 May 2026. » More on finanzen.net
MPH Health Care shares react positively to insider purchase by Brillant 4339. GmbH

On July 31, 2025, Brillant 4339. GmbH purchased 1,900,000 shares of MPH Health Care at €18.40 each. Following the disclosure of this insider trade, the price of MPH Health Care shares on the FSE rose by 11.10 percent to €18.55. Investors were initially undecided before the stock gained after the announcement. » More on finanzen.net

Historical dividends Dividends

All dividend metrics All metrics

In 2026, MPH Health Care has already paid €5.00 in dividends. The last payout was in July.

Financials

In the last quarter, MPH Health Care had revenue of €111.11k and net profit of €5.01m

(EUR)	June 2026	YoY
Revenue	111.11k	-
Gross profit	82.66k	-
Net profit	5.01m	-
EBITDA	5.43m	-

Fundamentals

Metric	Value
Market capitalization	€120.31m
Number of shares	4.28m
52-week high/low	€29.70 - €17.45
Dividend yield	17.73%
Dividends TTM	€5.00
Beta	1.05
P/E ratio	1.12
PEG ratio	0.00
P/B ratio	0.48
P/S ratio	0.34

Company profile

MPH Health Care AG, an investment company, engages in the healthcare business in Germany. It produces and sells medicinal products for the therapies of cancer, HIV, and other chronic diseases. The company also offers medical aesthetic treatments; and develops and sells pharmaceutical and medical products; and provides related services, as well as medical devices for the aesthetic surgery and cosmetic dermatology. In addition, it is involved in the provision of cytostatic solutions; and real estate activities. The company was formerly known as MPH Mittelständische Pharma Holding AG and changed its name to MPH Health Care AG in 2017. The company was founded in 2008 and is based in Berlin, Germany. MPH Health Care AG is a subsidiary of Magnum AG.

Name	MPH Health Care
CEO	Patrick Brenske
Headquarters	Berlin, be Germany
Website	mph-ag.de
Sector	Health Care
Industry	Health Care Providers & Services
IPO	16/05/2011
Employees	2